Back close

Combating Candida Albicans by Targeting the Virulence Factors

Dept/Center/Lab: Antimicrobial Resistance 

School: School of Biotechnology

Project Incharge:Dr. Geetha Kumar
Co-Project Incharge:Nimisha M.
Combating Candida Albicans by Targeting the Virulence Factors

In the fight against Candida albicans resistance and infections, a new strategy is emerging: targeting virulence factors. These are the fungal “weapons” that allow Candida albicans to invade and damage tissues. Drugs that interfere with pleomorphism, biofilm formation, protease synthesis, and adhesion molecules can be developed to disarm the fungus and stop it from doing damage. This strategy could be revolutionary since it targets drug-resistant strains and provides a more focused treatment with fewer adverse effects. Despite ongoing research, virulence factor targeting presents a possible avenue for future Candida albicans resistance.

Related Projects

Escherichia Coli based microfluidic whole-cell glucose biosensor
Escherichia Coli based microfluidic whole-cell glucose biosensor
Antimicrobial Activity of Selected Plant Extracts on Multi Drug Resistant Staphylococcus Aureus
Antimicrobial Activity of Selected Plant Extracts on Multi Drug Resistant Staphylococcus Aureus
Studies on Binding of Probiotic Strains to Host Extracellular Matrix Protein, Gelatin and Analysis of its Stability with Different Substrates
Studies on Binding of Probiotic Strains to Host Extracellular Matrix Protein, Gelatin and Analysis of its Stability with Different Substrates
Green Synthesis of Metal Nanoparticles & its Applications
Green Synthesis of Metal Nanoparticles & its Applications
The Discovery of MicroRNAs (miRNAs) that Regulate the Expression of Gelatinase A (Matrix metalloproteinase-2/MMP-2) and B (Matrix metalloproteinase-9/MMP-9) in Colon Cancer Cells
The Discovery of MicroRNAs (miRNAs) that Regulate the Expression of Gelatinase A (Matrix metalloproteinase-2/MMP-2) and B (Matrix metalloproteinase-9/MMP-9) in Colon Cancer Cells
Admissions Apply Now